Second-quarter Sales of AstraZeneca's COVID-19 Vaccine More Than Tripled to $894 Million ... - Latest Tweet by Reuters

Second-quarter sales of AstraZeneca's COVID-19 vaccine more than tripled to $894 million from the first quarter, but the drugmaker again delayed its U.S. application for approval as it gathers more data for submissions https://t.co/c7TZhZ0bEa pic.twitter.com/8qTszXIsWD— Reuters (@Reuters) July 29, 2021

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)